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Magnetic resonance imaging (MRI) and com- 
puted tomography (CT) are routinely used in 
female pelvis imaging. MRI is primarily use-
ful for locoregional characterization of benign 
and malignant diseases. CT is less accurate in 
locoregional evaluation, but remains useful in 
the follow-up of treated gynecological malig-
nancies, as well as in the setting of emergency 
and in the guidance of biopsies. Although 
transabdominal and transvaginal ultrasonog-
raphy (US) is not under the scope of this chap-
ter, it remains the first-line imaging method 
for most gynecological conditions.
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1  Introduction
Magnetic resonance imaging (MRI) and com-
puted tomography (CT) are routinely used in 
female pelvis imaging. MRI has a higher soft- 
tissue contrast and allows an accurate anatomic 
characterization of the pelvis as a whole, and a 
detailed depiction of the zonal anatomy. Thus, it is 
primarily useful for locoregional characterization 
of benign and malignant diseases. CT is less accu-
rate in locoregional evaluation, but remains useful 
in the follow-up of treated gynecological malig-
nancies, as well as in the setting of emergency 
(assessment of postsurgical complications and 
pelvic infectious diseases) and in the guidance of 
biopsies. Although transabdominal and transvagi-
nal ultrasonography (US) is not under the scope 
of this chapter, it remains the first-line imaging 
method for most gynecological conditions.
This chapter aims to focus on some important, 
hands-on topics regarding MRI and CT tech-
niques, trying not to exhaustively develop issues 
with isolated historical interest.
2  Magnetic Resonance 
Imaging
2.1  Introduction
The introduction of modern phased-array coils 
with eight or more elements led to high signal-to- 
noise ratios (SNR) and consequently increased 
image quality. Additionally, pelvic examinations 
have become faster as turbo (TSE) and fast spin- 
echo (FSE) sequences have replaced conven-
tional spin-echo (SE) sequences. Most MRI 
examinations are now performed at 1.5 and 3 
Tesla (T) magnets. Despite significant improve-
ment on SNR with higher field strength, 3 T mag-
nets are more prone to magnetic susceptibility 
artifacts, which may be particularly prominent on 
diffusion-weighted imaging (DWI).
2.2  Patient Preparation 
and Positioning
Before performing an MR exam, the patient 
should be informed about its approximate dura-
tion as well as the necessity to use earplugs to 
protect against loud noises and to place a surface 
coil close to the skin. Moreover, all patients 
should be asked about contraindications and 
claustrophobia. Sedation may be required for 
those patients who would really benefit from the 
examination, but are unable to proceed due to 
claustrophobia. Any implanted device must be 
previously known and considered to be safe for 
the patient undergoing an MR procedure. 
Intrauterine devices (IUD) can be normally 
scanned, and usually appear as a hypointense lin-
ear structure within the endometrial cavity on 
both T2-weighted images (T2WI).
Finally, patients should also be informed 
about the utility of intravenous (IV) contrast and 
spasmolytic agent administration, as well as  their 
side effects (see next sections).
Whenever a pregnant woman is undergoing an 
MR exam, issues about the fetus development are 
raised. As a general rule, the risk-benefit ratio 
should be evaluated for every patient. Fetal dele-
terious effects have not been documented on 
1.5 T magnets. However, some experts still rec-
ommend avoiding the exam in the first trimester 
unless the potential benefits compensate the 
hypothetical risks. Since most of the studies were 
performed on 1.5 T scanners, far less is known 
about potential effects on 3 T (Masselli et al. 
2013; Ray et al. 2016).
Some authors advocate that patients should 
void about 1 h before the examination to 
ensure that the bladder is only moderately 
filled. A full bladder may hamper T2WI and 
give rise to motion artifacts due to patient 
discomfort.
A 4-h fast helps to reduce bowel peristalsis 
and is recommended in some centers when intra-
venous contrast administration is required. The 
administration of a fast-acting laxative enema to 
clean the bowel may also improve image 
quality.
It is uncommon to perform bowel preparation 
with diluted barium sulfate or other solutions as it 
increases preparation and imaging time and does 
not seem to bring significant advantages.
Vaginal tampon should be avoided. Vaginal 
opacification with ultrasound gel makes the eval-
uation of vaginal walls easy and may be recom-
mended when studying vagina tumors and deep 
endometriosis. Moreover, rectal and/or vaginal 
opacification with ultrasound gel may be useful 
in dynamic pelvic floor and deep endometriosis 
studies (Beddy et al. 2012; Sala et al. 2013; 
Bazot et al. 2016).
Female pelvis imaging is usually performed 
with patients in supine position with the arms 
placed by their side. The placement of a bolster 
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under the knees makes the examination more 
comfortable. Two important procedures are 
generally taken in order to decrease motion 
artifacts during abdominal and pelvic examina-
tions: the use of a belt covering phased-array 
body coils, which restricts respiratory excur-
sions, and the application of a spatial presatura-
tion slab in a sagittal scout view, which is 
particularly useful in sequences without breath-
hold, because of its ability to reduce artifacts 
from the movement of the anterior abdominal 
wall (Sala et al. 2013; Forstner et al. 2016; 
Froehlich et al. 2009).
2.2.1  Spasmolytic Medication
The administration of antispasmodic agents such 
as scopolamine N-butyl bromide (Buscopan®) or 
glucagon is indicated to reduce artifacts from 
small bowel and bladder motion. It is particu-
larly useful in the assessment of peritoneal 
implants on both morphological and functional 
sequences, especially on DWI. The administra-
tion of intravenous Buscopan® (20–40 mg) 
immediately before the examination is the most 
consensual option. Longer examinations may 
justify a second identical dose, because IV 
Buscopan® action only lasts about 15 min. 
Intramuscular (IM) administration (20 mg) has 
an increased length of action (approximately 
30–60 min). This anticholinergic drug should 
not be administered in patients who have demon-
strated prior hypersensitivity to scopolamine 
N-butyl bromide, as well as in those with myas-
thenia gravis, narrow- angle glaucoma, megaco-
lon, tachycardia, prostatic enlargement with 
urinary retention, paralytic ileus, or mechanical 
stenosis in the gastrointestinal tract. Data regard-
ing contraindications during pregnancy is scarce; 
therefore Buscopan® is not recommended. 
Common undesirable effects may be accommo-
dation disorders, tachycardia, dizziness, or dry 
mouth. If accommodation changes occur, 
patients should be advised not to drive.
When Buscopan® is contraindicated, gluca-
gon (1 mg) can be administrated intravenously 
(Beddy et al. 2012; Sala et al. 2013; Bazot et al. 
2016). In a study of Froehlich et al., glucagon 
had more reliable onset of action and induced 
longer bowel paralysis when compared to sco-
polamine N-butyl bromide. Glucagon is contra-
indicated in patients with known hypersensitivity 
to the substance, as well as in those with known 
pheochromocytoma (due to the risk of stimulat-
ing catecholamine release). In patients with a 
known insulinoma, glucagon should be adminis-
tered cautiously since its initial hyperglycemic 
effect may stimulate the release of insulin and 
cause subsequent hypoglycemia (Froehlich et al. 
2009).
2.3  Coils, Scan Planes, 
and General Protocols
Female pelvic MRI is generally performed with 
a phased-array body coil with at least four ele-
ments. The introduction of modern coils 
improved SNR and allowed parallel imaging, 
thus reducing scan time on T1W and T2W con-
ventional sequences. Intracavitary coils, either 
endovaginal or endorectal, have no current sci-
entific support (Sala et al. 2013; Allen et al. 
2014).
A general female pelvis protocol usually 
begins with a coronal localizer, which provides 
an anatomic overview of both lower abdomen 
and pelvis. It is helpful not only to guide pelvic 
sequences but also to exclude other conditions 
like hydronephrosis or renal malformations. Fast 
sequences like single-shot turbo or fast spin echo 
are generally used.
Specific protocols depend on the study target, 
but usually include an axial T1WI sequence and 
at least two T2WI sequences in different planes 
(Fig. 1). Dynamic contrast-enhanced magnetic 
resonance imaging (DCE-MRI) and DWI have 
become part of the standard imaging protocols 
for most of female pelvis MR examinations 
(Forstner et al. 2010, 2016; Allen et al. 2014; 
Sala et al. 2011).
Table 1 resumes a suitable general protocol 
for gynecological MRI. Specific parameters 
should always be adapted according to the mag-
net and coils available in each center.
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Fig. 1 Examples of different orientations on MRI in dis-
tinct patients. Axial T1W image of the pelvis (a). Axial 
T2W image through the pelvis showing the uterus with an 
endometrial carcinoma associated with a polyp (b). 
Oblique sagittal according to the uterine axis T2W image 
showing the normal uterine zonal anatomy and a cervical 
cancer (c). Oblique coronal according to the long axis of 
the uterus, parallel to the endometrial cavity (d). Axial 
oblique T2W image, perpendicular to the long axis of the 
cervix, for evaluation of parametrial invasion while stag-
ing a cervical cancer (e). Axial oblique TIW images after 
gadolinium with fat saturation, perpendicular to the long 
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2.3.1  T1- and T2-Weighted Imaging
Typical SE T1WI is usually performed to assess 
spontaneous hyperintense content that may cor-
respond to fat or blood. Axial fat-saturated T1WI 
in the same plane and with the same thickness 
should be performed for their distinction. Some 
centers perform T1W in- and opposed-phase 
images, which allow the detection of intravoxel 
lipid within masses (manifesting as a signal loss 
on the opposed-phase images). If a short scan 
time is needed, gradient-echo (GRE) sequences 
may be applied; however anatomic detail will be 
decreased. Fat saturation may also be achieved 
by the Dixon method, a chemical shift-based 
technique that acquires both in- and opposed- 
phase images simultaneously, thus allowing 
mathematical combinations into fat-only and 
water-only sequences. It results in a more uni-
form suppression of the fat signal, and allows the 
detection and quantification of microscopic lipid 
(Allen et al. 2014).
Multiplanar high-resolution nonfat-saturated 
T2W sequences are the most relevant for the 
majority of female pelvic diseases, because of 
their ability to depict uterine and ovarian zonal 
anatomy and to provide good contrast between 
normal and pathological tissues. TSE or FSE 
sequences are typically used. A single 3D T2W 
sequence with later multiplanar postprocessing 
can alternatively be performed. Single-shot TSE 
sequences during breath-hold (HASTE) may be 
useful in the coronal plane to exclude hydrone-
phrosis or to assess renal malformations.
Fat-suppressed T2W sequences are not rou-
tinely used for female pelvic imaging. However, 
they may be helpful to identify intraperitoneal, 
extraperitoneal, and endoluminal fluid; enlarged 
lymph nodes; and bone changes (for example, in 
the setting of bone metastases or of edematous 
changes due to postradiotherapy insufficiency 
fractures). When compared to nonfat-suppressed 
T2WI, it also helps to assess for macroscopic 
lipid content (Allen et al. 2014).
2.3.2  Diffusion-Weighted Imaging
DWI is a functional MR technique that assesses 
the random movement or the Brownian motion of 
water molecules in different physical media. The 
diffusion properties of a biological tissue are 
related to the amount of interstitial free water and 
permeability, therefore reflecting tissue  cellularity 
and presence of intact cellular membranes. In 
general, high-cellularity tumors show restricted 
diffusion when compared to normal tissue, 
because of their higher cellular density. 
Coagulative necrosis, highly viscous fluid, and 
Table 1 Suitable general protocol for gynecological 
MRI at a 1.5 T magnet
  • 4–6 h of fasting
  •  Voiding and ingestion of two glasses of water 1 
to 2 h before the exam
  • Avoid the use of vaginal tampon
  • Vaginal opacification with ultrasound gel
   –  May be useful for vaginal tumors and deep 
endometriosis
  •  Rectal and/or vaginal opacification with 
ultrasound gel
   –  May be useful for dynamic pelvic floor 
studies and deep endometriosis
  •  Administration of a fast-acting laxative enema to 
clean the bowel, one on the day before the exam and 
another during the morning of the exam (optional)
  • Supine position
  •  Pelvic phased-array coils with at least four 
elements
  • Belt covering phased-array body coils
  • Anterior and superior saturation band
  • Antispasmodic agents:
   – Buscopan 20/40 mg IM/IV
   – Glucagon 1 mg IV
  • Matrix: 512 × 512
  •  Coronal localizer: single-shot turbo or fast 
spin-echo
  •  Morphological sequences: axial T1WI and at 
least two different planes on T2WI (or single 3D 
T2WI with posterior multiplanar post processing)
  •  DWI: field-of-view and thickness equal to T2WI 
(preferentially axial)
   – Pelvis (b values: 0, 600 and 1000 s/mm2)
   – Abdomen (b values: 0, 500 and 1000 s/mm2)
   – High b values may reach 1200–1400 s/mm2
  •  DCE-MRI: 2D or 3D fat-suppressed T1W GRE 
sequence
   –  Scan plane, region of interest, and 
acquisition timing depending on the 
specific target of the study
   –  Gadolinium standard dose: 0.1 mmol Gd/
kg body weigh
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abscesses may behave similarly. DWI is per-
formed using two or more b values (a measure of 
the gradient strength), including one or more low 
b values (0 or 50 s/mm2) and a high b value 
(1000 s/mm2 or higher). Apparent diffusion coef-
ficients (ADC) are mathematical transformations 
of b value acquisitions that represent the slope of 
the line of the natural logarithm of signal inten-
sity (y-axis) versus b values (x-axis). ADC maps 
are displayed parametrically as grayscale images. 
Suspicious areas with true water molecule move-
ment restriction appear bright at high b values 
and dark on the ADC map. High b value 
sequences and the ADC map should always be 
interpreted together with morphological 
sequences to avoid potential pitfalls. In order to 
facilitate this evaluation, fusion images between 
T2WI and DWI may be generated. However, they 
can be altered by patient motion and bladder dis-
tention during the examination, which may 
change the relative position of pelvic organs.
Whole-body diffusion-weighted MRI proto-
cols have been developed over the last years, 
mainly for cancer staging and follow-up. Short- 
time examinations are now possible on both 1.5- 
and 3-T magnets due to the evolution of 
echo-planar and parallel imaging, generation of 
high-performance gradients, and introduction of 
phased-array multichannel surface coils. 
Advantages include absence of ionizing radiation 
and no injection of isotopes or intravenous con-
trast media (Sala et al. 2013; Whittaker et al. 
2009; Hameeduddin and Sahdev 2015; Qayyum 
2009).
2.3.3  Dynamic Contrast 
Enhancement
Gadolinium-based contrast agents act by shorten-
ing T1 relaxation time, which is better seen on 
T1WI. Thus, dynamic contrast-enhanced MRI 
(DCE-MRI) is usually performed using a 2D or 
3D fat-suppressed T1W GRE sequence. 3D 
sequences like volumetric interpolated breath- 
hold examination (VIBE) allow the acquisition of 
thinner slices. The injection should be preferen-
tially performed using an MR-compatible auto-
matic injector, but manual administration may 
also be performed. Serial image acquisitions are 
then performed every few seconds over a length 
of a few minutes. The protocol—including scan 
plane, region of interest, and acquisition time—
will depend on the specific target of the study 
(see appropriate chapters). Qualitative, semi-
quantitative, and quantitative analysis may be 
performed. The enhancement of a given structure 
may be directly and qualitatively accessed as an 
area of increased signal intensity (SI) on 
T1WI. Semiquantitative analysis implies record-
ing the SI of a region of interest before and after 
contrast administration in order to get dynamic 
time-signal intensity (TSI) curves, which enable 
the extraction of some data like time to onset of 
enhancement, relative signal intensity, maximum 
postcontrast SI-to-precontrast SI ratio, rate of 
enhancement, and area under the curve (overall 
enhancement). Quantitative analysis—namely 
Ktrans (volume transfer constant between the 
plasma and the extracellular extravascular 
space)—remains under study and is not currently 
available in many centers (Beddy et al. 2012; 
Hameeduddin and Sahdev 2015; Bernardin et al. 
2012).
Initial unenhanced imaging is helpful to detect 
hyperintense hemorrhagic or proteinaceous con-
tent, and also allows performing subtraction 
imaging, which requires cautious breath-holding 
instructions to guarantee similar registration 
between unenhanced and contrast-enhanced 
images. Regardless of those instructions, some 
artifacts may be found due to bladder filling dur-
ing the examination.
2.4  Gadolinium-Based Contrast 
Media
A standard dose of 0.1 mmol/kg body weight of 
gadolinium is typically administered. For MR 
angiography, it may be increased to 0.2 mmol/kg 
body weight. The risk of nephrotoxicity is very 
low when gadolinium-based contrast media are 
used in approved doses (Beckett et al. 2015).
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The risk of an acute reaction to a 
gadolinium- based contrast agent is low when 
compared to iodine-based contrast agents. 
However, similar cautions should be taken. 
Risk patients are those with a history of previ-
ous acute reaction to gadolinium- based con-
trast agent, asthma, and allergy requiring 
medical treatment. Unlike iodine-based con-
trast agents, the risk of reaction to gadolinium-
based contrast agents is not related to 
osmolality (Beckett et al. 2015).
Nephrogenic systemic fibrosis (NSF) is rec-
ognized as a very late reaction to gadolinium-
based contrast media since 2006. It usually starts 
with pain, pruritus, swelling, and erythema in the 
legs, and progresses to thickening of the skin and 
subcutaneous tissues, as well as to fibrosis of 
internal organs and respiratory muscles, which 
may lead to variable consequences ranging from 
contractures to cachexia and death. The severity 
of the disease implies the prompt recognition of 
high- risk patients, which are those with chronic 
kidney disease (CKD) 4 and 5 (GFR <30 mL/
min), including patients on dialysis, and those 
with acute kidney insufficiency. Gadolinium-
based contrast agents with higher risk of NSF are 
gadodiamide (DTPA-BMA), gadopentetate 
dimeglumine (DTPA), and gadoversetamide 
(DTPA-BMEA). These high-risk agents should 
never be given in higher doses than 0.1 mmol/kg 
and are contraindicated in patients with stage 4 
and 5 CKDM, including those on dialysis, in 
patients with acute renal insufficiency, in preg-
nant women, and in neonates (Beckett et al. 
2015; Thomsen et al. 2013, 2016; Mathur and 
Weinreb 2016).
Low-risk gadolinium contrast agents may be 
used in pregnancy when there is a strong need 
and no neonatal tests are necessary. Lactating 
women are frequently object of concern. If the 
above-mentioned high-risk agents are used, 
breastfeeding should be stopped for 24 h (Beckett 
et al. 2015; Thomsen et al. 2013, 2016; Mathur 
and Weinreb 2016).
3  CT Technique
3.1  Introduction
The advent of helical scanning movement and 
multislice data collection gave rise to a new era 
of fast and high-resolution acquisitions.
Modern CT scans show substantial improve-
ment on volume coverage, scan speed, as well as 
a more efficient use of X-ray tubes. Helical CT 
scans allow near-isotropic acquisitions, thus 
enabling high-resolution multiplanar reconstruc-
tions (MPR) and volume rendering. Moreover, 
the detector size decreased and multiple arrays 
were incorporated inside. Therefore, several 
slices can be recorded simultaneously, shortening 
the exposure time; thus thinner slices can be 
obtained and partial volume artifacts can be 
decreased.
The high speed of current CT scanners allows 
a complete thoracic, abdominal, and pelvic exam-
ination in only one breath-hold. A CT pelvic 
acquisition is rarely performed alone. The scan is 
usually extended to the upper abdomen not only 
for staging and for the follow-up of malignant dis-
eases but also when characterization of vascular, 
inflammatory, or infectious entities is needed.
By shortening the scan time, motion artifacts 
are also reduced and distinct phases of enhance-
ment may be accurately obtained after  intravenous 
contrast administration. Overall, multidetector 
CT (MDCT) scans yield high spatial, temporal, 
and contrast resolution, thus increasing diagnostic 
accuracy. MDCT has rapidly evolved from 
4-detector row systems to 256- slice and 320-detec-
tor row CT systems. Currently, most centers use 
scanners with at least 8- to 16-detector rows. 
Submillimeter or millimeter volumetric acquisi-
tions with subsequent reconstruction into 2–5 mm 
thick axial, sagittal, and coronal images is a suit-
able protocol for routine CT scans (Thomsen 
et al. 2016; Rydberg et al. 2000; Goldman 2007; 
Yitta et al. 2009) (Fig. 2). Table 2 resumes a suit-
able general protocol for gynecological CT scans.
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Fig. 2 Examples of different orientations on CT in three 
distinct patients. Axial image, after oral and intravenous 
contrast administration, depicting anterior peritoneal carci-
nomatosis (arrow) in a patient with endometrial carcinoma 
(a). Sagittal image, after oral contrast administration (intra-
venous contrast was contraindicated), showing ascites and 
huge solid peritoneal implants (arrow) in a patient with 
ovarian carcinoma (b). Coronal image, after intravenous 
contrast administration, identifying an acute appendicitis 
(arrow) in a young patient during early puerperium (c)
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3.2  Technical Disadvantages
Among the main disadvantages of CT, there are 
two with great relevance in daily practice: ioniz-
ing radiation exposure and metallic artifacts. 
Despite the kind of CT scan, radiation reduction 
and protection should always be considered. 
Both technicians and radiologists should be 
familiarized with some technical features includ-
ing the tube current, X-ray beam collimation, and 
pitch, and cautiously select both the number and 
length of scan sequences. Dose quantification 
parameters like volume CT dose index (CTDlvol) 
and dose-length product (DLP) are usually dis-
played in current CT scans and should be rou-
tinely checked. Hip prosthesis causes substantial 
artifacts due to photon starvation and beam hard-
ening, consequently hampering not only the joint 
and the surrounding muscles, but also pelvic 
organs. Methods may be used to reduce these 
artifacts: filtered back projection (FBP), which 
uses information from areas adjacent to regions 
affected by metal artifacts and replaces the metal- 
corrupted raw data by the interpolated values; 
adaptive filtering, which corrects the excessive 
noise produced by the photon starvation effect; or 
iterative algorithms, which use a combination of 
different metal artifact reduction algorithms and 
algebraic reconstruction techniques (Morsbach 
et al. 2013). Iterative reconstruction techniques 
also enable performing reduced-dose CT exami-
nations (due to either tube current or tube poten-
tial lowering) without altering image quality 
(Padole et al. 2014).
3.3  Patient Preparation 
and Positioning
Before a CT scan, an inquiry about the patient 
medical history, routine medication, and potential 
contraindications is mandatory. Pregnancy is not a 
formal contraindication to CT; however, it should 
be avoided mainly during the first trimester. 
Patient preparation for CT scans is mainly related 
to contrast material administration (see next sec-
tions). Due to the need of intravenous contrast, 
patients are optimally asked to fast at least for 4 h. 
Administrating a fast-acting laxative enema to 
clean the bowel may also be recommended.
Patients are usually scanned in supine and 
“foot-first” positions, with their arms raised 
above their heads. Claustrophobic patients 
 tolerate lying with the head outside the gantry 
better. Moreover, these positions allow for a face-
to-face communication with the patient and facil-
itate the access to the patient whenever the 
examination has to be interrupted. “Foot-first” 
positioning also eases the connection of contrast 
medium tubes, which can be done immediately 
after inserting the venous access.
3.4  Oral and Rectal Contrast
Oral and rectal contrast media are frequently used 
in abdominal and pelvic CT imaging. Classically, 
it is given in cases of suspected bowel perforation 
or of anastomosis leakage. However, opacification 
Table 2 Suitable general protocol for gynecological CT 
at a 64-detector scanner
  • 4–6 h of fasting
  •  Administration of a fast-acting laxative enema to 
clean the bowel, one on the day before the exam 
and another during the morning of the exam 
(optional)
  •  Water or iodine-based oral contrast: 1000–
1500 mL of contrast medium administered in 
separate doses 45 to 60 min prior to the 
examination
  •  Water or iodine-based rectal contrast: catheter 
and enema bag; 200 mL to the rectosigmoid and 
900–1200 mL to the entire colon
  • Supine and “foot-first” positions
  • Range from diaphragm to pubic bone
  • Inspiration
  • Scout image: 120 kV, 10–50 mA
  • Final acquisition: (20 kV, 100–200 mAs)
  •  Sub-mm or mm volumetric acquisitions with 
subsequent reconstruction into 2 to 5 mm thick 
axial, sagittal and coronal images
  •  Correction of hip prosthesis artifacts if need: 
filtered back projection, adaptive filtering or 
iterative algorithms
  •  Intravenous iodine-based contrast: 100–150 mL 
at 3–4 mL/s
  • Scan delay
   – 70–100 s (covering all range)
   –  3–5 min (if pelvic vein thrombosis is 
suspected)
   –  5–10 min (if bladder and ureteral 
opacification is needed)
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of the digestive tract is also helpful for distinguish-
ing collapsed loops from lymph nodes, peritoneal 
implants, pelvic masses, and fluid collections.
Water as negative or positive iodinated solutions 
may be used for bowel opacification. In female pel-
vis imaging, positive contrast is particularly useful 
for staging and follow-up of ovarian and endome-
trial cancer. Iodinated solutions are preferable over 
barium suspensions due to its moderate effect on 
peristalsis and easier distribution along the diges-
tive tract. Contrarily, barium suspensions are more 
prone to flocculate and may give rise to streak arti-
facts that hamper wall evaluation. Both types of 
contrast are usually safe, with only rare cases of 
mild diarrhea being reported. However, if bowel 
perforation is suspected, only iodinated solution 
should be administered due to the higher peritoneal 
toxicity of barium-based contrast media. As 1–2% 
of oral contrast is absorbed through the gut patients 
who had previous moderate to severe IV contrast 
allergy should be managed carefully.
Protocols for oral contrast vary according to 
the center. Typically, 1000–1500 mL of contrast 
medium is ingested in separate doses 45–60 min 
prior to the examination. Some authors advocate 
the administration of 20 mg metoclopramide at 
the beginning of the ingestion, in order to shorten 
patient preparation.
Rectal contrast is administered when the patient 
lies on the scanning table by using a  catheter and 
an enema bag. 200 mL of contrast usually opaci-
fies the rectum and the sigmoid colon adequately, 
whereas the entire colon may require 900–
1200 mL of contrast. Sometimes, anal diseases 
like hemorrhoids and fissures hamper the intro-
duction of the rectal tube due to pain. Special care 
should also be taken in patients with anal and 
lower third rectal carcinoma due to the risk of 
ulceration or perforation (Beckett et al. 2015).
3.5  Intravenous Iodine-Based 
Contrast Media
Intravenous iodine-based contrast media are usu-
ally given as a rapid bolus via an IV cannula, by 
using a pump injector. A suitable protocol for 
abdominal and pelvic CT scan is to administer 
100–150 mL of 350 mg iodine contrast media at 
3–4 mL/s. As the time to contrast material arrival 
and peak enhancement are affected by the choice 
of intravenous access sites, particularly when 
forearm or hand veins are used, lower flow rates 
are desirable (Bae 2010).
A suitable routine gynecological CT scan 
includes the upper abdomen and is acquired 
70–100 s after contrast injection. Liver metasta-
ses from gynecological malignancies are typi-
cally hypovascular, so an arterial phase is usually 
unnecessary. Delayed images are recommended 
whenever pelvic vein thrombosis is suspected 
(3–5 min) or bladder and ureteral opacification is 
needed (5–10 min).
In order to reduce the risk of an acute reaction 
to iodine-based contrast media, some procedures 
should be taken according to the European 
Society of Urogenital Radiology (ESUR) guide-
lines: a nonionic contrast medium should be 
used; the patient should be kept in the Radiology 
Department for 30 min after the injection; and 
drugs and equipment for resuscitation have to be 
readily available. For patients at increased risk of 
reaction (history of previous moderate or severe 
acute reaction to an iodine-based contrast agent, 
asthma, and allergy requiring medical treatment), 
an alternative imaging tool not requiring an 
iodine-based contrast agent should be consid-
ered. The use of premedication for allergy 
 prevention is widely accepted, despite its 
 underlying limited clinical evidence. The ESUR 
guidelines recommend oral administration of 
prednisolone 30 mg (or methylprednisolone 
32 mg), 12 and 2 h before contrast medium 
administration (Thomsen et al. 2016).
There is usually some concern regarding thy-
rotoxicosis, a potential very late reaction to 
iodine-based contrast media that usually occurs 
more than 1 week after injection. As a general 
rule, iodinated contrast media should not be given 
to patients with manifest hyperthyroidism. 
Patients at risk—those with untreated Graves’ 
disease, or multinodular goiter and thyroid auton-
omy, especially if they are elderly and/or live in 
areas of dietary iodine deficiency—should be 
strictly monitored by endocrinologists after 
injection (Van der Molen et al. 2004).
Pregnancy and lactation are also usual sources 
of concern for both clinicians and radiologists. 
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Iodine-based contrast media may be given to 
pregnant patients in extraordinary conditions, but 
thyroid function should be checked in the neo-
nate during the first week following the exam. 
When iodine-based agents are given to lactating 
mothers, breastfeeding may be continued nor-
mally (Thomsen et al. 2016).
In patients with renal impairment (eGFR less 
45 mL/min/1.73 m2 for intravenous administra-
tion), an alternative imaging method without 
iodine-based contrast media should be consid-
ered. However, if it is really needed, volume 
expansion should be done. According to the 
ESUR guidelines, intravenous normal saline, 
1.0–1.5 mL/kg/h, for at least 6 h before and after 
contrast medium administration is recommended. 
An alternative suitable protocol is intravenous 
sodium bicarbonate (154 mEq/L in dextrose 5% 
water), 3 mL/kg/h for 1 h before contrast medium 
administration and 1 mL/kg/h for 6 h after con-
trast medium administration. Moreover, the low-
est dose of a low or iso-osmolar contrast medium 
should be used (Thomsen et al. 2016).
Finally, some recommendations should be 
followed in patients taking metformin due to the 
risk of lactic acidosis after IV iodine-based con-
trast exposure when significant renal impairment 
is present. Patients with an eGFR between 30 
and 44 mL/min/1.73 m2 (CKD 3) should stop 
metformin 48 h before contrast medium injec-
tion and should only restart it 48 h after the 
examination if renal function has not deterio-
rated. In patients with eGFR less than 30 mL/
min/1.73 m2 (CKD 4 and 5), iodine-based con-
trast media should be avoided (Beckett et al. 
2015; Thomsen et al. 2016).
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